Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Facial WastingFacial Wasting
         
Rollover images to visit our other forums!
 
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


My chances of reshaping my body with hiv?
Sep 28, 2008

I've been positive since 1988, presently on kaletra and epzicom. What can I do to lose extra fat? Don't want to look sick but can't be overweight and uncomfortable either

Response from Dr. Pierone

If you have extra fat related to lipohypertrophy, then this may be a complication related to cumulative exposure to HIV medications, and protease inhibitors are the leading culprit.

There are some studies that have shown improvement in lipohypertrophy when protease inhibitors (Kaletra in your case) are switched for non-nucleoside reverse transcriptase inhibitors (NNRTIs). If you have been on treatment with this class in the past and have virus that is resistant to these agents, then switching to them (Viramune or Sustiva) is not an option.

However, we now have a second generation non-nucleoside reverse transcriptase inhibitor called Intelence, so this may be an option. Additionally, an integrase inhibitor called Isentress is now available and I have seen improvement in lipohypertrophy after switching protease inhibitors to this agent.

I hope this information helps and best of luck!



  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering legal or medical advice or professional services. Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any sponsor is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement